Cathay Biotech Inc. (SHA:688065)

Market Cap	35.84B
Revenue (ttm)	3.29B
Net Income (ttm)	594.46M
Shares Out	720.66M
EPS (ttm)	0.92
PE Ratio	54.19
Forward PE	54.65
Dividend	0.40 (0.80%)
Ex-Dividend Date	Aug 1, 2025

Volume	3,274,540
Average Volume	3,647,978
Open	49.50
Previous Close	49.30
Day's Range	49.16 - 50.48
52-Week Range	36.81 - 56.16
Beta	0.55
RSI	49.58
Earnings Date	Oct 31, 2025

About Cathay Biotech

Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries. It provides its products under the TERRYL and ECOPENT brands. Cathay Biotech In...

• Industry: Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 1,735
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688065

Financial Performance

In 2024, Cathay Biotech's revenue was 2.96 billion, an increase of 39.91% compared to the previous year's 2.11 billion. Earnings were 488.96 million, an increase of 33.41%.